A retinoic acid-enhanced, multicellular human blood-brain barrier model derived from stem cell sources
Open accessThe DOI matches its Crossref record; 50 of the 51 references it cites were found in a registry or an index.
Abstract
Blood-brain barrier (BBB) models are often used to investigate BBB function and screen brain-penetrating therapeutics, but it has been difficult to construct a human model that possesses an optimal BBB phenotype and is readily scalable. To address this challenge, we developed a human in vitro BBB model comprising brain microvascular endothelial cells (BMECs), pericytes, astrocytes and neurons derived from renewable cell sources. First, retinoic acid (RA) was used to substantially enhance BBB phenotypes in human pluripotent stem cell (hPSC)-derived BMECs, particularly through adherens junction, tight junction, and multidrug resistance protein regulation. RA-treated hPSC-derived BMECs were subsequently co-cultured with primary human brain pericytes and human astrocytes and neurons derived from human neural progenitor cells (NPCs) to yield a fully human BBB model that possessed significant tightness as measured by transendothelial electrical resistance (~5,000 Ωxcm(2)). Overall, this scalable human BBB model may enable a wide range of neuroscience studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Other studies have shown mixed results regarding the effect of pericytes or other supporting cell types on TEER of dhBMEC monolayers [20, 33, 36, 41, 52–54].”
From Role of iPSC-derived pericytes on barrier function of iPSC-derived brain microvascular endothelial cells in 2D and 3D (2019) · cites this paper as [33]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A perivascular origin for mesenchymal stem cells in multiple human organs
Crisan, M., Yap, S., Casteilla, L., Chen, C.-W., Corselli, M., Park, T. S., Andriolo, G., Sun, B., Zheng, B., Zhang, L., et al. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.07.003 · Cited by 3,991
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280
The blood-brain barrier: Bottleneck in brain drug development
Pardridge, W. M. (2005) · NeuroRX · doi:10.1602/neurorx.2.1.3 · Cited by 2,798
Pericytes are required for blood–brain barrier integrity during embryogenesis
Daneman, R., Zhou, L., Kebede, A. A., & Barres, B. A. (2010) · Nature · doi:10.1038/nature09513 · Cited by 2,128
Blood‐brain barrier‐specific properties of a human adult brain endothelial cell line
Weksler, B. B., Subileau, E. A., Perrière, N., Charneau, P., Holloway, K., Leveque, M., Tricoire‐Leignel, H., Nicotra, A., Bourdoulous, S., Turowski, P., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-3458fje · Cited by 1,330
Central nervous system pericytes in health and disease
Winkler, E. A., Bell, R. D., & Zlokovic, B. V. (2011) · Nature Neuroscience · doi:10.1038/nn.2946 · Cited by 962
A Membrane Receptor for Retinol Binding Protein Mediates Cellular Uptake of Vitamin A
Kawaguchi, R., Yu, J., Honda, J., Hu, J., Whitelegge, J., Ping, P., Wiita, P., Bok, D., & Sun, H. (2007) · Science · doi:10.1126/science.1136244 · Cited by 836
Derivation of blood-brain barrier endothelial cells from human pluripotent stem cells
Lippmann, E. S., Azarin, S. M., Kay, J. E., Nessler, R. A., Wilson, H. K., Al-Ahmad, A., Palecek, S. P., & Shusta, E. V. (2012) · Nature Biotechnology · doi:10.1038/nbt.2247 · Cited by 800
Self-citationElectrical resistance across the blood-brain barrier in anaesthetized rats: a developmental study.
Butt, A. M., Jones, H. C., & Abbott, N. J. (1990) · The Journal of Physiology · doi:10.1113/jphysiol.1990.sp018243 · Cited by 775
A cell culture model of the blood-brain barrier.
Rubin, L. L., Hall, D. E., Porter, S., Barbu, K., Cannon, C., Horner, H. C., Janatpour, M., Liaw, C. W., Manning, K., & Morales, J. (1991) · The Journal of cell biology · doi:10.1083/jcb.115.6.1725 · Cited by 765
Cited by
Two new Later Stone Age sites from the Final Pleistocene in the Falémé Valley, eastern Senegal
Ndiaye, M., Lespez, L., Tribolo, C., Rassé, M., Hadjas, I., Davidoux, S., Huysecom, É., & Douze, K. (2024) · Monash University Research Portal (Monash University) · doi:10.3929/ethz-b-000667478 · Cited by 23,868
TEER Measurement Techniques for In Vitro Barrier Model Systems
Srinivasan, B., Kolli, A. R., Esch, M. B., Abaci, H. E., Shuler, M. L., & Hickman, J. J. (2015) · SLAS Technology · doi:10.1177/2211068214561025 · Cited by 2,145
“To replicate in vivo TEER values in BBB models, endothelial cells have been co-cultured with other brain cell types, exposed to physiological shear stress,(52) or treated with various chemicals.(53) The models using cell lines, such as hCMEC/D.”
MethodBlood-brain barrier dysfunction and recovery after ischemic stroke
Jiang, X., Andjelkovic, A. V., Zhu, L., Yang, T., Bennett, M. V. L., Chen, J., Keep, R. F., & Shi, Y. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.10.001 · Cited by 936
Helms, H. C., Abbott, N. J., Burek, M., Cecchelli, R., Couraud, P.-O., Deli, M. A., Förster, C., Galla, H. J., Romero, I. A., Shusta, E. V., et al. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16630991 · Cited by 843
“The stem cell-based models could additionally be used to interrogate other signaling pathways and developmental events such as those with the interacting cells of the NVU.(116,117,256) Moreover, with the hPSC system, it would also be possible to model diseased NVU phenotypes using endothelial and neural cells derived…”
BackgroundSelf-citationVatine, G. D., Barrile, R., Workman, M. J., Sances, S., Barriga, B. K., Rahnama, M., Barthakur, S., Kasendra, M., Lucchesi, C., Kerns, J., et al. (2019) · Cell stem cell · doi:10.1016/j.stem.2019.05.011 · Cited by 632
Park, T.-E., Mustafaoglu, N., Herland, A., Hasselkus, R., Mannix, R., FitzGerald, E. A., Prantil-Baun, R., Watters, A., Henry, O., Benz, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10588-0 · Cited by 594
Self-citationWang, Y. I., Abaci, H. E., & Shuler, M. L. (2017) · Biotechnology and Bioengineering · doi:10.1002/bit.26045 · Cited by 563
“…obtain high-fidelity human BMECs with BBB properties, we took the approach of directing human iPSCs toward neuroectoderm via biased spontaneous differentiation and subsequently purifying the BBB-like endothelial population on a selective matrix as previously described (Lippmann et al., 2012, 2014).”
BackgroundMethodInfluentialNeuronal regulation of the blood–brain barrier and neurovascular coupling
Kaplan, L., Chow, B. W., & Gu, C. (2020) · Nature Reviews Neuroscience · doi:10.1038/s41583-020-0322-2 · Cited by 430
Osaki, T., Uzel, S. G. M., & Kamm, R. D. (2018) · Science Advances · doi:10.1126/sciadv.aat5847 · Cited by 421
Cholesterol and matrisome pathways dysregulated in astrocytes and microglia
TCW, J., Qian, L., Pipalia, N. H., Chao, M. J., Liang, S. A., Shi, Y., Jain, B. R., Bertelsen, S. E., Kapoor, M., Marcora, E., et al. (2022) · Cell · doi:10.1016/j.cell.2022.05.017 · Cited by 411
The Molecular Constituents of the Blood–Brain Barrier
Chow, B. W., & Gu, C. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2015.08.003 · Cited by 380
“Intriguingly, studies reported that human pluripotent stem cells treated with retinoic acid can differentiate to endothelial cells displaying BBB properties[72,73].”
Wevers, N. R., Kasi, D. G., Gray, T., Wilschut, K. J., Smith, B., van Vught, R., Shimizu, F., Sano, Y., Kanda, T., Marsh, G., et al. (2018) · Fluids and Barriers of the CNS · doi:10.1186/s12987-018-0108-3 · Cited by 353
A Stable and Reproducible Human Blood-Brain Barrier Model Derived from Hematopoietic Stem Cells
Cecchelli, R., Aday, S., Sevin, E., Almeida, C., Culot, M., Dehouck, L., Coisne, C., Engelhardt, B., Dehouck, M.-P., & Ferreira, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099733 · Cited by 349
“Recently, a human in vitro BBB model from iPSCs has been reported [4,29].”
BackgroundMicrofluidic organ-on-chip technology for blood-brain barrier research
van der Helm, M. W., van der Meer, A. D., Eijkel, J. C. T., van den Berg, A., & Segerink, L. I. (2016) · Tissue Barriers · doi:10.1080/21688370.2016.1142493 · Cited by 333
“In contrast, advances have been made in deriving brain-specific endothelial cells from human induced pluripotent stem cells (hiPSC).(57,58) This development holds great promise for personalized (or precision) medicine, since brain endothelium can be derived from both “healthy” cells and “diseased” cells (e.”
BackgroundMarx, U. (2016) · ALTEX · doi:10.14573/altex.1603161 · Cited by 295
“…(Szkolnicka et al., 2014), cardiomyocytes (Burridge et al., 2014), small intestine (Kauffman et al., 2013), neurons (Hoelting et al., 2013; Lippmann et al., 2014; Lancaster and Knoblich, 2014; Terrasso et al., 2015; Simão et al., 2016), lung (Ghaedi et al., 2013), gallbladder (Kauffman et…”
Appelt-Menzel, A., Cubukova, A., Günther, K., Edenhofer, F., Piontek, J., Krause, G., Stüber, T., Walles, H., Neuhaus, W., & Metzger, M. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.02.021 · Cited by 274
“The addition of stimulating compounds such as retinoic acid (RA) during differentiation (Lippmann et al., 2014) and co-culturing with individual niche cell types, such as pericytes, astrocytes, and neural cells, have further improved BBB properties (Lippmann et al., 2013; Cecchelli et al., 2014).”
BackgroundMethodResultInfluentialBridging barriers: a comparative look at the blood–brain barrier across organisms
O'Brown, N. M., Pfau, S. J., & Gu, C. (2018) · Genes & Development · doi:10.1101/gad.309823.117 · Cited by 263
“Recent work has sought to use human induced pluripotent stem cells (iPSCs) (Lippmann et al. 2014; Lim et al. 2017; Vatine et al. 2017) to model human BBB function in vitro.”
BackgroundNeuronal and vascular interactions
Andreone, B. J., Lacoste, B., & Gu, C. (2015) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-071714-033835 · Cited by 256
Directed differentiation of human pluripotent stem cells to blood-brain barrier endothelial cells
Qian, T., Maguire, S. E., Canfield, S. G., Bao, X., Olson, W. R., Shusta, E. V., & Palecek, S. P. (2017) · Science Advances · doi:10.1126/sciadv.1701679 · Cited by 254
Self-citationLim, R. G., Quan, C., Reyes-Ortiz, A. M., Lutz, S. E., Kedaigle, A. J., Gipson, T. A., Wu, J., Vatine, G. D., Stocksdale, J., Casale, M. S., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.04.021 · Cited by 253
“These cells were differentiated into BMECs as described (Lippmann et al., 2014) and in Supplemental Information.”
InfluentialCanfield, S. G., Stebbins, M. J., Morales, B. S., Asai, S. W., Vatine, G. D., Svendsen, C. N., Palecek, S. P., & Shusta, E. V. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.13923 · Cited by 250
Self-citationIn Vitro Models of the Blood-Brain Barrier
Neuhaus, W. (2020) · Handbook of Experimental Pharmacology · doi:10.1007/164_2020_370 · Cited by 236
Vatine, G. D., Al-Ahmad, A., Barriga, B. K., Svendsen, S., Salim, A., Garcia, L., Garcia, V. J., Ho, R., Yucer, N., Qian, T., et al. (2017) · Cell Stem Cell · doi:10.1016/j.stem.2017.04.002 · Cited by 233
“The physical barrier presented by the BBB limits paracellular molecular diffusion, and it is provided by tight junctions (TJs) between adjacent BMECs (Lippmann et al., 2012, 2014; Pardridge, 2012).”
BackgroundMethodSelf-citationThe blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2
Krasemann, S., Haferkamp, U., Pfefferle, S., Woo, M. S., Heinrich, F., Schweizer, M., Appelt-Menzel, A., Cubukova, A., Barenberg, J., Leu, J., et al. (2022) · Stem Cell Reports · doi:10.1016/j.stemcr.2021.12.011 · Cited by 229
3D in vitro modeling of the central nervous system
Hopkins, A. M., DeSimone, E., Chwalek, K., & Kaplan, D. L. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.11.003 · Cited by 228
Lu, T. M., Houghton, S., Magdeldin, T., Durán, J. G. B., Minotti, A. P., Snead, A., Sproul, A., Nguyen, D.-H. T., Xiang, J., Fine, H. A., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2016950118 · Cited by 224
“In summary, iBMECs can be obtained from PSCs using either the original method (1) or subsequently derived protocols (1, 2, 9, 18).”
InfluentialAdvances in Microfluidic Blood–Brain Barrier (BBB) Models
Oddo, A., Peng, B., Tong, Z., Wei, Y., Tong, W. Y., Thissen, H., & Voelcker, N. H. (2019) · Trends in Biotechnology · doi:10.1016/j.tibtech.2019.04.006 · Cited by 221
A Historical Review of Brain Drug Delivery
Pardridge, W. M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14061283 · Cited by 219
In Vitro Models of the Blood–Brain Barrier for the Study of Drug Delivery to the Brain
Wilhelm, I., & Krizbai, I. A. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500046f · Cited by 211
Neal, E. H., Marinelli, N. A., Shi, Y., McClatchey, P. M., Balotin, K. M., Gullett, D. R., Hagerla, K. A., Bowman, A. B., Ess, K. C., Wikswo, J. P., et al. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.05.008 · Cited by 208
“The addition of retinoic acid (RA) during the differentiation process further enhanced passive barrier function (TEER 3,000 U 3 cm(2)) (Lippmann et al., 2014a).”
BackgroundSelf-citationLinville, R. M., DeStefano, J. G., Sklar, M. B., Xu, Z., Farrell, A. M., Bogorad, M. I., Chu, C., Walczak, P., Cheng, L., Mahairaki, V., et al. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2018.10.023 · Cited by 199
“Human induced pluripotent stem cells (iPSCs) differ entiated into BMECs (dhBMECs) display many of the hallmarks of the BBB in two-dimensional (2D) transwell assays including physiological TEER, permeability and efflux behavio r.(13-16) Interestingly, BBB phenotype is achieved without supporting cell types.”
Human pluripotent stem cell–derived brain pericyte–like cells induce blood-brain barrier properties
Stebbins, M. J., Gastfriend, B. D., Canfield, S. G., Lee, M.-S., Richards, D., Faubion, M. G., Li, W.-J., Daneman, R., Palecek, S. P., & Shusta, E. V. (2019) · Science Advances · doi:10.1126/sciadv.aau7375 · Cited by 195
Self-citationWolff, A., Antfolk, M., Brodin, B., & Tenje, M. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24329 · Cited by 191
Hollmann, E. K., Bailey, A. K., Potharazu, A. V., Neely, M. D., Bowman, A. B., & Lippmann, E. S. (2017) · Fluids and Barriers of the CNS · doi:10.1186/s12987-017-0059-0 · Cited by 189
“For comparison, UM-derived BMECs exhibited maximum TEER of 3980 ± 151 Ω × cm2 24 h after barrier induction, a value comparable to previously published results [25], and maintained stability for a similar timeframe as E6-derived BMECs (Fig.”
Self-citationManu, D. R., Slevin, M., Barcutean, L., Forro, T., Boghitoiu, T., & Balasa, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417146 · Cited by 181
“In a human in vitro BBB model comprising brain microvascular endothelial cells (BMECs), pericytes, astrocytes, and neurons, RA-treated BMECs expressed VE-cadherin, occludin, and claudin-5 [46,47].”
Stebbins, M. J., Wilson, H. K., Canfield, S. G., Qian, T., Palecek, S. P., & Shusta, E. V. (2016) · Methods · doi:10.1016/j.ymeth.2015.10.016 · Cited by 179
“BMECs also exhibit responsiveness to other cells from the neurovascular unit, such as pericytes and astrocytes and neurons, offering the ability to examine cellular crosstalk at the BBB [19,23].”
BackgroundInfluentialSelf-citationEffect of shear stress on iPSC-derived human brain microvascular endothelial cells (dhBMECs)
DeStefano, J. G., Xu, Z. S., Williams, A. J., Yimam, N., & Searson, P. C. (2017) · Fluids and Barriers of the CNS · doi:10.1186/s12987-017-0068-z · Cited by 153
“In contrast to other cell lines, dhBMECs under static conditions exhibit transendothelial electrical resistance values in excess of 2000 Ω cm2 [5, 6, 79], comparable to values reported in vivo in rat brains (1000–1500 Ω cm2) [80].”
Stem Cell-Based Human Blood–Brain Barrier Models for Drug Discovery and Delivery
Aday, S., Cecchelli, R., Hallier-Vanuxeem, D., Dehouck, M. P., & Ferreira, L. (2016) · Trends in Biotechnology · doi:10.1016/j.tibtech.2016.01.001 · Cited by 169
“After this initial report, the BBB phenotype of these hPSCderived BECs was improved by the addition of retinoic acid (RA), which promotes the expression of VE-cadherin and occludin [16].”
BackgroundFantastic voyage: the journey of intestinal microbiota-derived microvesicles through the body
Stentz, R., Carvalho, A. L., Jones, E. J., & Carding, S. R. (2018) · Biochemical Society Transactions · doi:10.1042/bst20180114 · Cited by 168
Human iPSC-Derived Endothelial Cells and Microengineered Organ-Chip Enhance Neuronal Development
Sances, S., Ho, R., Vatine, G., West, D., Laperle, A., Meyer, A., Godoy, M., Kay, P. S., Mandefro, B., Hatata, S., et al. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.02.012 · Cited by 167
“BMECs were differentiated as described previously (Lippmann et al., 2014).”
Singh, A. V., Chandrasekar, V., Janapareddy, P., Mathews, D. E., Laux, P., Luch, A., Yang, Y., Canibaño, B., Balakrishnan, S., Abinahed, J. A., et al. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00087 · Cited by 164
Regulation of ABC Transporters Blood–Brain Barrier
Miller, D. S. (2015) · Advances in cancer research · doi:10.1016/bs.acr.2014.10.002 · Cited by 163
Carthy, D. J. M., Malhotra, M., O’Mahony, A., Cryan, J. F., & O’Driscoll, C. M. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1545-6 · Cited by 160
“Additional work by this group resulted in an all human BBBmodel using stemcell derived components as well as primary human cells (170).”
BackgroundMethodRaimondi, I., Izzo, L., Tunesi, M., Comar, M., Albani, D., & Giordano, C. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00435 · Cited by 155
96 perfusable blood vessels to study vascular permeability in vitro
van Duinen, V., van den Heuvel, A., Trietsch, S. J., Lanz, H. L., van Gils, J. M., van Zonneveld, A. J., Vulto, P., & Hankemeier, T. (2017) · Scientific Reports · doi:10.1038/s41598-017-14716-y · Cited by 129
Logan, S., Arzua, T., Canfield, S. G., Seminary, E. R., Sison, S. L., Ebert, A. D., & Bai, X. (2019) · Comprehensive physiology · doi:10.1002/cphy.c180025 · Cited by 153
Ribecco-Lutkiewicz, M., Sodja, C., Haukenfrers, J., Haqqani, A. S., Ly, D., Zachar, P., Baumann, E., Ball, M., Huang, J., Rukhlova, M., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-19522-8 · Cited by 148
Modeling Alzheimer's disease with human induced pluripotent stem (iPS) cells
Mungenast, A. E., Siegert, S., & Tsai, L.-H. (2016) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2015.11.010 · Cited by 127
“…multiple research groups are focusing on creating vascularization, as shown for liver tissue (Masumoto et al., 2014; Samuel et al., 2013; Takebe et al., 2013) or blood–brain-barrier structures from iPS cells (Lippmann et al., 2014; Lippmann et al., 2013; Lippmann et al., 2012; Minami et al., 2015).”
BackgroundNew experimental models of the blood-brain barrier for CNS drug discovery
Kaisar, M. A., Sajja, R. K., Prasad, S., Abhyankar, V. V., Liles, T., & Cucullo, L. (2017) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2017.1253676 · Cited by 135
“the specific signaling mechanisms involved in human BBB development [111,119,122].”
BackgroundModeling the blood–brain barrier: Beyond the endothelial cells
Gastfriend, B. D., Palecek, S. P., & Shusta, E. V. (2018) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2017.11.002 · Cited by 129
Self-citationGomez-Zepeda, D., Taghi, M., Scherrmann, J.-M., Decleves, X., & Menet, M.-C. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics12010020 · Cited by 124
“After differentiation and isolation, the hPSC-derived brain endothelial cells monolayers present key BBB characteristics, including tight junctions and functional ABC transporters [158,159,172].”
BackgroundBenchmarking in vitro tissue-engineered blood–brain barrier models
DeStefano, J. G., Jamieson, J. J., Linville, R. M., & Searson, P. C. (2018) · Fluids and Barriers of the CNS · doi:10.1186/s12987-018-0117-2 · Cited by 142
Complex Tissue and Disease Modeling using hiPSCs
Passier, R., Orlova, V., & Mummery, C. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2016.02.011 · Cited by 142
“…cardiomyopathy (Han et al., 2014; Lan et al., 2013), LEOPARD syndrome, and arrhythmogenic right ventricular cardiomyopathy (Kim et al., 2013; Ma et al., 2013), the disease phenotype manifested as increased cardiomyocyte size in culture, with sarcomeric disorganization and contractile…”
BackgroundRecent progress in translational engineered in vitro models of the central nervous system
Nikolakopoulou, P., Rauti, R., Voulgaris, D., Shlomy, I., Maoz, B. M., & Herland, A. (2020) · Brain · doi:10.1093/brain/awaa268 · Cited by 143
“Since then, a plethora of studies on hiPSC-derived BMEC-like cells emerged, using similar (Lippmann et al. , 2014; Hollmann et al. , 2017) or conceptually different differentiation strategies (Orlova et al. , 2014).”
Recent advances in human iPSC-derived models of the blood–brain barrier
Workman, M. J., & Svendsen, C. N. (2020) · Fluids and Barriers of the CNS · doi:10.1186/s12987-020-00191-7 · Cited by 141
Tumor-on-chip modeling of organ-specific cancer and metastasis
Del Piccolo, N., Shirure, V. S., Bi, Y., Goedegebuure, S. P., Gholami, S., Hughes, C. C. W., Fields, R. C., & George, S. C. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.05.008 · Cited by 126
de Rus Jacquet, A., Alpaugh, M., Denis, H. L., Tancredi, J. L., Boutin, M., Decaestecker, J., Beauparlant, C., Herrmann, L., Saint-Pierre, M., Parent, M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39038-8 · Cited by 120
“To determine if astrocytes could contribute to BBB dysfunction in PD, we differentiated BMEC-like cells following a published protocol 64,65 and established a human iPSC-based 3D model that recapitulates the unique cytoarchitecture and microenvironment of the neurovascular unit (NVU) (Fig.”
Therapeutic strategies for spinal muscular atrophy: SMN and beyond
Bowerman, M., Becker, C. G., Yáñez‐Muñoz, R. J., Ning, K., Wood, M. J. A., Gillingwater, T. H., & Talbot, K. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.030148 · Cited by 137
“Furthermore, iPSCs can also be used to generate endothelial cells (Lippmann et al., 2014) to model the blood-brain barrier (BBB; Box 1) that protects the CNS, but also limits the entry of therapeutic compounds (Abbott, 2013; Pardridge, 2005), thus allowing screening of novel and established drugs…”
BackgroundWilson, H. K., Canfield, S. G., Hjortness, M. K., Palecek, S. P., & Shusta, E. V. (2015) · Fluids and Barriers of the CNS · doi:10.1186/s12987-015-0007-9 · Cited by 130
“For example, while H9 hESCs required an extended length of EC treatment phase of 4 days in order to achieve substantial TEER using Versene colony passage [15], controlling the day 0 hPSC seeding density using the singularizedcell seeding approach reported here allowed H9-generated BMECs to achieve high TEER using the…”
BackgroundMethodResultSelf-citationKatt, M. E., Xu, Z. S., Gerecht, S., & Searson, P. C. (2016) · PLOS ONE · doi:10.1371/journal.pone.0152105 · Cited by 129
“have also reported physiological TEER values for iPSC-derived hBMECs treated with retinoic acid [17].”
BackgroundMethodInfluentialGlial-endothelial crosstalk regulates blood–brain barrier function
Cheslow, L., & Alvarez, J. I. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2015.09.010 · Cited by 125
Faal, T., Phan, D. T. T., Davtyan, H., Scarfone, V. M., Varady, E., Blurton-Jones, M., Hughes, C. C. W., & Inlay, M. A. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.01.005 · Cited by 124
“Furthermore, maximal BMEC TEER was observed at day 2 of co-culture with pericytes, which supports the findings of previous studies (AppeltMenzel et al., 2017; Lippmann et al., 2014).”
BackgroundMethodResultInfluentialStructure and Function of the Blood–Brain Barrier (BBB)
Benz, F., & Liebner, S. (2020) · Handbook of experimental pharmacology · doi:10.1007/164_2020_404 · Cited by 123
Canfield, S. G., Stebbins, M. J., Faubion, M. G., Gastfriend, B. D., Palecek, S. P., & Shusta, E. V. (2019) · Fluids and Barriers of the CNS · doi:10.1186/s12987-019-0145-6 · Cited by 113
Self-citationJamieson, J. J., Linville, R. M., Ding, Y. Y., Gerecht, S., & Searson, P. C. (2019) · Fluids and Barriers of the CNS · doi:10.1186/s12987-019-0136-7 · Cited by 117
Sriram, G., Tan, J. Y., Islam, I., Rufaihah, A. J., & Cao, T. (2015) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0260-5 · Cited by 115
“Human cord blood-derived endothelial progenitors [49] and hPSCs [50, 51] upon coculture with neural cells differentiate to brain-specific ECs and express markers and functions related to the blood– brain barrier.”
BackgroundHDL from an Alzheimer's disease perspective
Button, E. B., Robert, J., Caffrey, T. M., Fan, J., Zhao, W., & Wellington, C. L. (2019) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000604 · Cited by 114
Commentary on human pluripotent stem cell-based blood–brain barrier models
Lippmann, E. S., Azarin, S. M., Palecek, S. P., & Shusta, E. V. (2020) · Fluids and Barriers of the CNS · doi:10.1186/s12987-020-00222-3 · Cited by 114
Self-citationChiou, B., Neal, E. H., Bowman, A. B., Lippmann, E. S., Simpson, I. A., & Connor, J. R. (2019) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x18783372 · Cited by 105
Self-citationBiology of the human blood-nerve barrier in health and disease
Ubogu, E. E. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113272 · Cited by 112
Organ‐On‐A‐Chip Models of the Blood–Brain Barrier: Recent Advances and Future Prospects
Kawakita, S., Mandal, K., Mou, L., Mecwan, M. M., Zhu, Y., Li, S., Sharma, S., Hernández, A. L., Nguyen, H. T., Maity, S., et al. (2022) · Small · doi:10.1002/smll.202201401 · Cited by 112
Martinez, A., & Al-Ahmad, A. J. (2018) · Toxicology Letters · doi:10.1016/j.toxlet.2018.12.013 · Cited by 111
Self-citationFowler, S., Chen, W. L. K., Duignan, D. B., Gupta, A., Hariparsad, N., Kenny, J. R., Lai, W. G., Liras, J., Phillips, J. A., & Gan, J. (2020) · Lab on a Chip · doi:10.1039/c9lc00857h · Cited by 109
Lin, Y., Gil, C.-H., & Yöder, M. C. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.309962 · Cited by 111
Yue, Q., & Hoi, M. P. M. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.367832 · Cited by 107
“…1) (El Hafny et al., 1997), as well as attenuating endothelial inflammation (ICAM-1, vascular cell adhesion molecule 1) against inflammatory insults probably via activating antioxidant nuclear factor erythroid 2-related factor 2 (NRF2) pathway (Lippmann et al., 2014; Mizee et al., 2014).”
Faley, S. L., Neal, E. H., Wang, J. X., Bosworth, A. M., Weber, C. M., Balotin, K. M., Lippmann, E. S., & Bellan, L. M. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.01.009 · Cited by 106
“Optimization of the Hydrogel Scaffold for Endothelial Adhesion We first optimized scaffold composition and determined that iPSC-derived BMECs performed best when seeded on gelatin hydrogels coated with collagen IV and fibronectin (Figure S1), an approach determined to be effective in previously published protocols (Ho…”
BackgroundMethodSelf-citationNishihara, H., Gastfriend, B. D., Soldati, S., Perriot, S., Mathias, A., Sano, Y., Shimizu, F., Gosselet, F., Kanda, T., Palecek, S. P., et al. (2020) · The FASEB Journal · doi:10.1096/fj.202001507rr · Cited by 99
Self-citationIn vitro modeling of blood–brain barrier and interface functions in neuroimmune communication
Erickson, M. A., Wilson, M., & Banks, W. A. (2020) · Fluids and Barriers of the CNS · doi:10.1186/s12987-020-00187-3 · Cited by 104
Blood–Brain Barrier Breakdown in Neuroinflammation: Current In Vitro Models
Brandl, S., & Reindl, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612699 · Cited by 104
Stanimirovic, D. B., Bani-Yaghoub, M., Perkins, M., & Haqqani, A. S. (2015) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2015.974545 · Cited by 83
“The BBB phenotype of these stem-cell derived BEC was further enhanced by the RA [51] via inducing an earlier onset of VE-cadherin expression, higher tight junction complexity, and mRNA upregulation of multiple efflux pumps (e.”
BackgroundKatt, M. E., Linville, R. M., Mayo, L. N., Xu, Z. S., & Searson, P. C. (2018) · Fluids and Barriers of the CNS · doi:10.1186/s12987-018-0092-7 · Cited by 102
“The lack of physiologically relevant BMEC lines has been a major roadblock to blood–brain barrier (BBB) research [3], however, stem cell technology has provided a potential solution to this problem [4].”
BackgroundINPP5D regulates inflammasome activation in human microglia
Chou, V., Pearse, R. V., Aylward, A. J., Ashour, N., Taga, M., Terzioglu, G., Fujita, M., Fancher, S. B., Sigalov, A., Benoit, C. R., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-42819-w · Cited by 101
“Using established protocols, we also generated iPSC-derived astrocytes (iAs) 24 , induced neurons (iNs) 25,26 , and iPSC-derived endo-thelialcells(iECs) 27,28 andevaluatedINPP5Dexpressionineachofthese cell types using western blotting.”
MethodControlling Differentiation of Stem Cells for Developing Personalized Organ‐on‐Chip Platforms
Geraili, A., Jafari, P., Hassani, M. S., Araghi, B. H., Mohammadi, M. H., Ghafari, A. M., Tamrin, S. H., Modarres, H. P., Kolahchi, A. R., Ahadian, S., et al. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201700426 · Cited by 88
Advances in microphysiological blood-brain barrier (BBB) models towards drug delivery
Lee, C. S., & Leong, K. W. (2020) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2020.06.009 · Cited by 94
Williams, I. M., & Wu, J. C. (2019) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.119.312265 · Cited by 91
Mantle, J. L., Min, L., & Lee, K. H. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00818 · Cited by 86
Blood–Brain Barrier and Neurodegenerative Diseases—Modeling with iPSC-Derived Brain Cells
Wu, Y.-C., Sonninen, T.-M., Peltonen, S., Koistinaho, J., & Lehtonen, Š. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147710 · Cited by 89
“A study by Nishihara et al. showed that brain ECs differentiated through two established protocols (Lippmann et al. 2014 and Qian et al. 2017) did not express the full array of adhesion molecules [198].”
BackgroundOikari, L. E., Pandit, R., Stewart, R., Cuní-López, C., Quek, H., Sutharsan, R., Rantanen, L. M., Oksanen, M., Lehtonen, S., de Boer, C. M., et al. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2020.03.011 · Cited by 90
“hiPSCderived iBECs express key proteins of BECs, demonstrate high barrier integrity and exhibit efflux transporter activity characteristic of the BBB in vivo (Lippmann et al., 2014).”
BackgroundMethodInfluentialNano-scale architecture of blood-brain barrier tight-junctions
Sasson, E., Anzi, S., Bell, B., Yakovian, O., Zorsky, M., Deutsch, U., Engelhardt, B., Sherman, E., Vatine, G. D., Dzikowski, R., et al. (2021) · eLife · doi:10.7554/elife.63253 · Cited by 95
Tissue Engineering the Vascular Tree
Traoré, M. A., & George, S. C. (2017) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2017.0010 · Cited by 92
Morofuji, Y., & Nakagawa, S. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200224112534 · Cited by 90
Models of the blood-brain barrier using iPSC-derived cells
Delsing, L., Herland, A., Falk, A., Hicks, R., Synnergren, J., & Zetterberg, H. (2020) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2020.103533 · Cited by 73
The blood-brain barrier studied in vitro across species
Thomsen, M. S., Humle, N., Hede, E., Moos, T., Burkhart, A., & Thomsen, L. B. (2021) · PLOS ONE · doi:10.1371/journal.pone.0236770 · Cited by 79
“When the BBB phenotype is enhanced by the addition of retinoic acid, the TEER values can be increased even further to approximately 5000 Ω�cm(2) [72].”
BackgroundEngineering the human blood-brain barrier in vitro
Jamieson, J. J., Searson, P. C., & Gerecht, S. (2017) · Journal of Biological Engineering · doi:10.1186/s13036-017-0076-1 · Cited by 72
“PSC-derived Mouse or human iPSC or ESC 250–5350 [19, 101, 102] • renewable source • patient specific • physiological TEER • require differentiation and thorough characterization [20, 101, 102, 112] Jamieson et al.”
BackgroundIn vitro models of molecular and nano-particle transport across the blood-brain barrier
Hajal, C., Campisi, M., Mattu, C., Chiono, V., & Kamm, R. D. (2018) · Biomicrofluidics · doi:10.1063/1.5027118 · Cited by 77
Noumbissi, M. E., Galasso, B., & Stins, M. F. (2018) · Fluids and Barriers of the CNS · doi:10.1186/s12987-018-0097-2 · Cited by 77
The next generation of endothelial differentiation: Tissue-specific ECs
Nguyen, J., Lin, Y.-Y., & Gerecht, S. (2021) · Cell stem cell · doi:10.1016/j.stem.2021.05.002 · Cited by 82
Pong, S., Karmacharya, R., Sofman, M., Bishop, J. R., & Lizano, P. L. (2020) · Complex Psychiatry · doi:10.1159/000511552 · Cited by 81
Modarres, H. P., Janmaleki, M., Novin, M., Saliba, J., Moussa, F. E. H., Charan, M. R., Seyfoori, A., SadAbadi, H., Vandal, M., Nguyen, M. D., et al. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.01.024 · Cited by 80
Page, S., Munsell, A., & Al-Ahmad, A. J. (2016) · Fluids and Barriers of the CNS · doi:10.1186/s12987-016-0042-1 · Cited by 80
“The IMR90 cell line was differentiated into BMECs (iPSC-BMECs) following the differentiation protocol established by Lippmann and colleagues [20, 21] and summarized in Additional file 1: Figure S1.”
Self-citation
Metadata
- Authors
- Lippmann, E. S., Al-Ahmad, A., Azarin, S. M., Palecek, S. P., & Shusta, E. V.
- Affiliations
- University of Wisconsin–Madison (US)
- Corresponding author
- Palecek, Sean P.
- Shusta, Eric V.
- Venue
- Scientific Reports
- Published
- 2014-02-24
- Volume
- 4
- Issue
- 1
- Pages
- 4160-4160
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC3932448
- OpenAlex
- W2042883482
- Cited by
- 508
- References
- 51
- Citations by year
- 2026: 23 · 2025: 39 · 2024: 45 · 2023: 55 · 2022: 56 · 2021: 45 · 2020: 58 · 2019: 54 · 2018: 41 · 2017: 34 · 2016: 26 · 2015: 22 · 2014: 10
- FWCI
- 15.93
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/3.0/ (tdm)
- creativecommons.org/licenses/by-nc-nd/3.0/ (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Science Foundation (NS083688)
- Cedars-Sinai Medical Center
- Beijing Municipal Education Commission
- National Institutes of Health
- National Institute on Alcohol Abuse and Alcoholism (AA020476, RC4AA020476)
- National Cancer Institute (P30CA014520)
- National Institute of General Medical Sciences (T32GM008505)
- National Institute of Neurological Disorders and Stroke (R01NS083688, NS083688)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Keywords
- blood-brain barrier model, retinoic acid, human pluripotent stem cells, brain microvascular endothelial cells, pericytes, astrocytes, neural progenitor cells, tight junctions, adherens junctions, multidrug resistance protein, transendothelial electrical resistance, co-culture
- MeSH terms
- Astrocytes, Blood-Brain Barrier, Brain, Cell Differentiation, Cells, Cultured, Electric Conductivity, Endothelium, Vascular, Humans, Models, Biological, Neurons, Tretinoin, Coculture Techniques, Pericytes, Pluripotent Stem Cells, Neural Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.